MX9805507A - Composicion para la transfeccion de celulas eucarioticas superiores. - Google Patents
Composicion para la transfeccion de celulas eucarioticas superiores.Info
- Publication number
- MX9805507A MX9805507A MX9805507A MX9805507A MX9805507A MX 9805507 A MX9805507 A MX 9805507A MX 9805507 A MX9805507 A MX 9805507A MX 9805507 A MX9805507 A MX 9805507A MX 9805507 A MX9805507 A MX 9805507A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- transfection
- eucaryotic cells
- higher eucaryotic
- approximately
- Prior art date
Links
- 238000001890 transfection Methods 0.000 title abstract 3
- 239000002253 acid Substances 0.000 abstract 1
- -1 cationic lipid Chemical class 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19605548A DE19605548A1 (de) | 1996-02-15 | 1996-02-15 | Zusammensetzung für die Transfektion höherer eukaryotischer Zellen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9805507A true MX9805507A (es) | 1998-11-29 |
Family
ID=7785445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9805507A MX9805507A (es) | 1996-02-15 | 1998-07-07 | Composicion para la transfeccion de celulas eucarioticas superiores. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0900281A1 (enExample) |
| JP (1) | JP2000504579A (enExample) |
| CA (1) | CA2246227A1 (enExample) |
| DE (1) | DE19605548A1 (enExample) |
| MX (1) | MX9805507A (enExample) |
| WO (1) | WO1997030170A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2766705B1 (fr) * | 1997-07-30 | 2001-05-25 | Biovector Therapeutics | Complexe particulaire de charge globale neutre ou negative forme d'une vesicule cationique ou neutre et d'une substance biologiquement active anionique, leur preparation et leur utilisation |
| FR2766706B1 (fr) * | 1997-07-30 | 2001-05-25 | Biovector Therapeutics Sa | Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation |
| GB9918670D0 (en) | 1999-08-06 | 1999-10-13 | Celltech Therapeutics Ltd | Biological product |
| GB0120022D0 (en) * | 2001-08-16 | 2001-10-10 | Photobiotics Ltd | Conjugate |
| ES2646669T3 (es) | 2010-07-06 | 2017-12-14 | Glaxosmithkline Biologicals Sa | Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN |
| SI2591114T1 (sl) | 2010-07-06 | 2016-10-28 | Glaxosmithkline Biologicals S.A. | Imunizacija velikih sesalcev z majhnimi odmerki RNA |
| AU2011276234B2 (en) | 2010-07-06 | 2016-02-25 | Glaxosmithkline Biologicals S.A. | Liposomes with lipids having an advantageous pKa- value for RNA delivery |
| WO2012031043A1 (en) | 2010-08-31 | 2012-03-08 | Novartis Ag | Pegylated liposomes for delivery of immunogen-encoding rna |
| EP3520813B1 (en) | 2010-10-11 | 2023-04-19 | GlaxoSmithKline Biologicals S.A. | Antigen delivery platforms |
| EP3854413A1 (en) | 2011-07-06 | 2021-07-28 | GlaxoSmithKline Biologicals SA | Immunogenic combination compositions and uses thereof |
| EP4014966A1 (en) | 2011-07-06 | 2022-06-22 | GlaxoSmithKline Biologicals S.A. | Liposomes having useful n:p ratio for delivery of rna molecules |
| WO2013051718A1 (ja) | 2011-10-07 | 2013-04-11 | 国立大学法人三重大学 | キメラ抗原受容体 |
| AU2016301196B2 (en) | 2015-08-06 | 2022-09-08 | Dana-Farber Cancer Institute, Inc. | Tunable endogenous protein degradation |
| US11052111B2 (en) | 2015-12-08 | 2021-07-06 | Chimera Bioengineering, Inc. | Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses |
| EP4342978A3 (en) | 2016-09-01 | 2024-07-03 | Chimera Bioengineering Inc. | Gold optimized car t-cells |
| EP3580212A4 (en) | 2017-02-08 | 2021-03-17 | Dana Farber Cancer Institute, Inc. | REGULATION OF CHEMERIC ANTIGEN RECEPTORS |
| US20240216509A1 (en) | 2018-05-07 | 2024-07-04 | Children's Hospital Medical Center | Chimeric polypeptides, nucleic acid molecules, cells, and related methods |
| JPWO2020213724A1 (enExample) | 2019-04-19 | 2020-10-22 | ||
| JPWO2020246563A1 (enExample) | 2019-06-05 | 2020-12-10 | ||
| CN116194124A (zh) | 2020-07-31 | 2023-05-30 | 中外制药株式会社 | 包含表达嵌合受体的细胞的药物组合物 |
| US20240150472A1 (en) | 2021-03-17 | 2024-05-09 | Daiichi Sankyo Company, Limited | Gene coding for chimeric receptor for anti-acetylcholine receptor autoantibody |
| US20240366666A1 (en) | 2021-04-08 | 2024-11-07 | Phosphogam, Llc | Methods and compositions for enhancing the cytotoxicity of gamma/delta-t cells |
| WO2024150525A1 (ja) | 2023-01-12 | 2024-07-18 | 国立大学法人山口大学 | 抗ネコｐｄ－１抗体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ244306A (en) * | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
| US5578475A (en) * | 1993-07-12 | 1996-11-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
| FR2714830B1 (fr) * | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
| US5928944A (en) * | 1994-02-04 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method of adenoviral-medicated cell transfection |
| EP0874910A4 (en) * | 1995-06-07 | 1999-04-21 | Life Technologies Inc | ENHANCED CATIONIC LIPID TRANSFECTION BY PEPTIDES |
| IL115199A (en) * | 1995-09-07 | 2005-05-17 | Opperbas Holding Bv | Composition comprising a polynucleic acid molecule in a liposome and method using said composition |
-
1996
- 1996-02-15 DE DE19605548A patent/DE19605548A1/de not_active Ceased
-
1997
- 1997-02-13 JP JP9528984A patent/JP2000504579A/ja not_active Abandoned
- 1997-02-13 CA CA002246227A patent/CA2246227A1/en not_active Abandoned
- 1997-02-13 EP EP97904426A patent/EP0900281A1/de not_active Withdrawn
- 1997-02-13 WO PCT/EP1997/000649 patent/WO1997030170A1/de not_active Ceased
-
1998
- 1998-07-07 MX MX9805507A patent/MX9805507A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000504579A (ja) | 2000-04-18 |
| WO1997030170A1 (de) | 1997-08-21 |
| EP0900281A1 (de) | 1999-03-10 |
| DE19605548A1 (de) | 1997-09-04 |
| CA2246227A1 (en) | 1997-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL81737A0 (en) | Regulation of gene expression in plant cells | |
| EP0196387A3 (en) | Method of increasing the cell voltage of electrochemical cells | |
| CA2078189A1 (en) | Mammalian artificial chromosomes | |
| FR2731216B1 (fr) | Composes d'insertion carbones et leur utilisation en tant qu'anodes dans des batteries rechargeables | |
| GB2185347B (en) | Platinum alloy electrocatalyst and acid-electrolyte fuel cell electrode using the same | |
| DE3066086D1 (en) | Electrochemical cell and gas diffusion electrode for the same | |
| GR861665B (en) | Enzyme composition stable in dry bleaching | |
| IL134897A0 (en) | Expression of genes in hematopoietic stem cells in ischemic conditions | |
| AU4266597A (en) | Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell | |
| HUP9700429A2 (en) | Nucleic acid constructs for the cell cycleregulated expression of genes, cells containing such constructs and their use for preparing drugs | |
| ZA888942B (en) | Electrochemical cell | |
| PL337942A1 (en) | Isolated genes of dendricall cell membranic proteins | |
| GB8828640D0 (en) | Electrochemical cell | |
| TR200001046T2 (tr) | Homolog rekombinasyonda pozitif-negatif seçimi. | |
| CA2220226A1 (en) | Improved methods for transfecting t cells | |
| GB8717859D0 (en) | Electrochemical cell | |
| AU2468992A (en) | Method of gene delivery to post-mitotic cells | |
| DE3570695D1 (en) | Dry enzyme formulations containing d-amino acid oxidase | |
| HUT56208A (en) | Rechargeable electrochemical cell, in particular primary cell | |
| IT1241123B (it) | Cellule umane per l'elevata espressione di geni inseriti in dna ricombinanti episomiali,loro preparazione e loro impiego | |
| GB2314332B (en) | Gene expression in mammalian cells | |
| IL83435A (en) | Dna construct for expression of genes in yeast, an expression vector containing it and yeast transformed with said expression vector | |
| GB2210727B (en) | Electrochemical cell | |
| GB2213310B (en) | Electrochemical cell | |
| GB8819240D0 (en) | Electrochemical cell |